Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Tuesday 19 January 2010 8:24 pm  |  Updated:  Saturday 01 June 2019 1:10 pm

Strong IBM result boosts tech shares

By: KCS-content

Add as a preferred source on Google

US stocks rose broadly yesterday, lifting the Dow and the S&P 500 to fresh 15-month closing highs as investors bet a potential Republican victory in Massachusetts’ Senate race could stall Obama’s reform agenda.

Wall Street also got a boost from technology shares, which rallied in anticipation of strong earnings from bellwether International Business Machines, which rose 1.8 per cent to $134.14, making it the Dow’s top boost.

Indeed, after the bell, IBM delivered quarterly earnings that beat Wall Street’s forecasts.

But healthcare shares rallied the most in the regular session on hopes that policy gridlock in Washington would slow the healthcare overhaul, removing a threat to the profits of insurers and drug companies.

The S&P Healthcare Index climbed 2 per cent, with drug company Eli Lilly, up 4.4 per cent at $37.41, among the standouts. Health insurers’ shares also rallied briskly, with Humana up 7.1 per cent at $51.94.

Massachusetts voters were deciding a tight race yesterday to replace the late Edward Kennedy, a Democrat. The loss of one seat in the US Senate could hurt the Democrats’ ability to proceed to a vote on the planned healthcare overhaul that seemed to be in the final stages.

“A Republican win would be a positive for the markets since it would mean increased potential for gridlock in Washington,” said Carmine Grigoli, chief US strategist at Mizuho Securities USA in New York. “This is probably especially true now, given the very large social agenda of the Obama administration.”

The Dow Jones industrial average jumped 115.78 points, or 1.09 per cent, to end at 10,725.43. The Standard & Poor’s 500 Index shot up 14.20 points, or 1.25 per cent, to 1,150.23. The Nasdaq Composite Index climbed 32.41 points, or 1.42 per cent, to 2,320.40.

The reform bills under debate in Congress would reshape the healthcare insurance market through new regulations, taxes and other changes. The healthcare overhaul is President Barack Obama’s top domestic priority, and the White House said that Obama does not believe healthcare reform is dead even should the Democrat, Martha Coakley, lose.

Health insurer Aetna gained 4.2 per cent to $32.66. Drugmaker Merck & Co, a Dow component, gained 3 percent to $40.62. The Dow also received a boost from McDonald’s after Credit Suisse upgraded the fast food giant, saying its international businesses were a potential driver of earnings.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Money

Related Topics

  • NULL

Trending Articles

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • Rachel Reeves to unveil next steps for ring-fencing reform at Mansion House

  • Wimbledon: HMRC set to slap Sinner and Noskova with £1.6m tax bill

  • Barclays and Lloyds back calls to digitalise UK markets and unlock £33bn boost

  • The former African gold miner taking on the billionaire Issa brothers

More from City PM

  • ‘Ugly moment’ for software stocks as IBM suffers biggest one-day slump in decades

    Tech
    All eyes on IBM v Lzlabs as the tech giant kicks off legal battle
  • Boots eyes £7.5bn sale in blow to hopes of London IPO

    Retail
    Boots remains one of the group’s best performing business lines, with a London float suggested as recently as last year. (Photo by Oli Scarff/Getty Images)
  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech
    GSK said total sales fell by two per cent in the third quarter
  • Consulting giants face up to AI-reckoning

    Consulting
    NYSE trading floor bustling with activity as traders monitor market trends and stock performance on electronic displays
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • THG reports boost in revenue after beauty and nutrition growth

    Markets
    THG owns e-commerce platform Cult Beauty.
  • Australian pharma giant Sigma quits Boots takeover talks

    Retail
    Anthony Hemmerdinger will take over the role from Seb James later this year.
  • Investec shares rise amid takeover speculation

    Investing
    Investec has selected the four winners of its Beyond Business programme

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook